Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Findings on Approaches to Consent – ARCHIVED

CHAPTER SECTIONS

ARCHIVED PAGE

Archived on June 3, 2025. Go to the latest version.

Consent, Waiver of Consent, and Notification


Section 5

Findings on Approaches to Consent – ARCHIVED

Expand Contributors

Pearl O’Rourke, MD

Kayte Spector-Bagdady, JD, MBE

David Wendler, PhD, MA

Contributing Editor

Karen Staman, MS

Preferences for Various Approaches

Research has been conducted on views about research and consent to understand individuals’ perspectives on various approaches. Findings include:

  • Most U.S. respondents prefer that conversations about participating in randomized or retrospective observational studies occur with their physician rather than with researchers. Most are comfortable using an alternative approach to written consent if research cannot otherwise take place, but would prefer to have a traditional consent form documented and signed (Cho et al 2015).
  • People are more likely to want notice of research when it involves use of health information (as compared to biospecimens), identified data and specimens (as compared to deidentified), and commercial research (as compared to academic) (Spector-Bagdady et al. 2022)
  • People believe their physicians will only propose worthwhile and safe research (Kelley et al 2015).
  • People are comfortable waiving consent for minimal-risk quality improvement activities (Kaplan et al 2016).
  • Effective policy and guidance on informed consent in comparative effectiveness research will involve balancing patients’ interests (Weinfurt et al 2016).
  • Differences in consent rates can be associated with recruitment methodology as well as prospective participant demographics including age, race and ethnicity, and socioeconomic status (Jones et al. 2020; Spector-Bagdady et al. 2022).

People generally endorse research, want to participate, and indicate comfort with alternate approaches. However, a substantial minority still want to be somewhat engaged in decision-making (Sugarman 2016). The data on individual preferences support the need to give some information even when the research qualifies for a waiver.

A series of web-based surveys comparing different models for notification and authorization in different types of comparative effectiveness research was conducted to determine the level of participant understanding and the acceptability of these approaches (Weinfurt et al 2017), and found that most participants had trouble understanding pragmatic trials. Based on these findings, the authors suggest that effort and resources be expended to develop, field, and test alternate approaches to notification and authorization (Weinfurt et al 2017). As research practices evolve, more work is needed to improve our understanding of people’s desire to receive information about the risks, burdens, and benefits of interventions and therapies involved in research.

Methodological Challenges for Studying Different Approaches to Disclosure/Notification and Authorization

In most of the research regarding people’s preferences, it is unclear whether people have a full understanding of the nature of the research being described or the differences between conventional research and related activities (eg, pragmatic research, quality improvement research, comparative effectiveness research). Our current understanding relies in large part on hypothetical examples, and may not reflect actual practice. To gain further insight, investigators need to be inquisitive about different approaches to notification and authorization and test them as part of future embedded trials. This will help determine acceptability of approaches across a spectrum of types of research (Sugarman 2016).

Previous Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction – ARCHIVED
  2. Regulatory Requirements for Informed Consent – ARCHIVED
  3. Waivers and Alterations – ARCHIVED
  4. Mechanisms for Notification – ARCHIVED
  5. Findings on Approaches to Consent – ARCHIVED

REFERENCES

back to top

Cho MK, Magnus D, Constantine M, et al. 2015. Attitudes toward risk and informed consent for research on medical practices: a cross-sectional survey. Ann Intern Med. 162:690-696. doi:10.7326/M15-0166. PMID: 25868119.

Jones RD, Krenz C, Gornick M, et al. 2020. Patient preferences regarding informed consent models for participation in a learning health care system for oncology. JCO Oncology Practice. 16:e977-e990. doi:10.1200/JOP.19.00300. PMID: 32352881

Kaplan SH, Gombosev A, Fireman S, et al. 2016. The patient’s perspective on the need for informed consent for minimal risk studies: development of a survey-based measure. AJOB Empirical Bioethics. 7:116-124. doi:10.1080/23294515.2016.1161672.

Kelley M, James C, Alessi Kraft S, et al. 2015. Patient perspectives on the learning health system: the importance of trust and shared decision making. Am J Bioeth. 15:4-17. doi:10.1080/15265161.2015.1062163. PMID: 26305741.

back to top

Spector-Bagdady K, Rahimzadeh V, Jaffe K, Moreno J. 2022. Promoting ethical deployment of artificial intelligence and machine learning in healthcare. Am J Bioethics. 22:4-7. doi:10.1080/15265161.2022.2059206. PMID: 35499568

Sugarman J. 2016. Ethics of research in usual care settings: data on point. AJOB Empirical Bioethics. 7:71-75. doi:10.1080/23294515.2016.1152104.

Weinfurt KP, Bollinger JM, Brelsford KM, et al. 2017. Comparison of approaches for notification and authorization in pragmatic clinical research evaluating commonly used medical practices. Med Care. doi:10.1097/MLR.0000000000000762. PMID: 28650924.

Weinfurt KP, Bollinger JM, Brelsford KM, et al. 2016. Patients’ views concerning research on medical practices: implications for consent. AJOB Empirical Bioethics. 7:76-91. doi:10.1080/23294515.2015.1117536. PMID: 27800531.


Version History

Published October 13, 2022

current section :

Findings on Approaches to Consent – ARCHIVED

  1. Introduction – ARCHIVED
  2. Regulatory Requirements for Informed Consent – ARCHIVED
  3. Waivers and Alterations – ARCHIVED
  4. Mechanisms for Notification – ARCHIVED
  5. Findings on Approaches to Consent – ARCHIVED

Citation:

O’Rourke P, Spector-Bagdady K, Wendler D. Consent, Waiver of Consent, and Notification: Findings on Approaches to Consent – ARCHIVED. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/ethics-and-regulatory/consent-waiver-of-consent-and-notification/findings-on-approaches-to-consent/. Updated December 3, 2025. DOI: 10.28929/165.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map